The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
BRIDGEBIO PHARMA INC COM 10806X102 73,797 2,544,738 SH   DFND   2,544,738 0 0
CORTEXYME INC COM 22053A107 47,450 1,040,343 SH   DFND   1,040,343 0 0
EVENTBRITE INC COM CL A 29975E109 307 42,102 SH   DFND 4 42,102 0 0
HEALTH CATALYST INC COM 42225T107 20,439 781,615 SH   DFND 3 781,615 0 0
HEALTH CATALYST INC COM 42225T107 60,343 2,307,576 SH   DFND 2 2,307,576 0 0
MEDALLIA INC COM 584021109 505,548 25,226,945 SH   DFND 3 25,226,945 0 0
MEDALLIA INC COM 584021109 204,414 10,200,307 SH   DFND 1 10,200,307 0 0
MEDALLIA INC COM 584021109 179,955 8,979,804 SH   DFND 5 8,979,804 0 0
PINDUODUO INC SPONSORED ADS 722304102 189,632 5,263,157 SH   DFND 6 5,263,157 0 0
SQUARE INC CL A 852234103 11,613 221,705 SH   DFND 2 221,705 0 0
SQUARE INC CL A 852234103 11,785 224,994 SH   DFND 4 224,994 0 0